Study of relationship between stress hyperglycemia and insulin-resistance related factors

Study of relationship between stress hyperglycemia and insulin-resistance related factors

OBJECTIVE: To observe related factors in the stress hyperglycemia (SHG) of critical illness and to investigate possible pathogenesis of insulin-resistance (IR)

Détails bibliographiques
Publié dans:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue. - 1998. - 18(2006), 12 vom: 14. Dez., Seite 751-4
Auteur principal: Cao, Xiang-yuan (Auteur)
Autres auteurs: Wang, Xiao-hong, Ma, Shao-lin, Yang, Xiao-jun, Wang, Xiao-qi, Ding, Huan, Liu, Ming, He, Lan-jie, Ma, Xiao-wei, Ma, Xi-gang
Format: Article
Langue:Chinese
Publié: 2006
Accès à la collection:Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue
Sujets:English Abstract Journal Article C-Peptide Insulin Tumor Necrosis Factor-alpha Glucagon 9007-92-5 Hydrocortisone WI4X0X7BPJ
LEADER 01000caa a22002652 4500
001 NLM167163000
003 DE-627
005 20250207205950.0
007 tu
008 231223s2006 xx ||||| 00| ||chi c
028 5 2 |a pubmed25n0557.xml 
035 |a (DE-627)NLM167163000 
035 |a (NLM)17166359 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a chi 
100 1 |a Cao, Xiang-yuan  |e verfasserin  |4 aut 
245 1 0 |a Study of relationship between stress hyperglycemia and insulin-resistance related factors 
264 1 |c 2006 
336 |a Text  |b txt  |2 rdacontent 
337 |a ohne Hilfsmittel zu benutzen  |b n  |2 rdamedia 
338 |a Band  |b nc  |2 rdacarrier 
500 |a Date Completed 06.06.2011 
500 |a Date Revised 21.11.2013 
500 |a published: Print 
500 |a Citation Status MEDLINE 
520 |a OBJECTIVE: To observe related factors in the stress hyperglycemia (SHG) of critical illness and to investigate possible pathogenesis of insulin-resistance (IR) 
520 |a METHODS: Blood glucose (BG), insulin (INS), C-peptide (C-P), cortisol (Cor), somatostatin (SS), glucagon (Gluc), tumor necrosis factor-alpha (TNF-alpha),soluble tumor necrosis factor receptor I (sTNFRI) and sTNFRII were determined respectively by radioimmunoassay (RIA) or enzyme linked immunoadsorbent assay (ELISA) in 47 SHG patients with critical illness and 15 healthy volunteers serving as normal controls. Their insulin sensitivity index (ISI) was calculated 
520 |a RESULTS: (1)Eleven of 47 patients died, while 36 cases survived. Mean acute pathology and chronic health evaluation II (APACHEII) was (13.89+/-6.29) scores within 24 hours after admission to intensive care unit (ICU), mean days of stay in ICU was (5.5+/-6.3) days,and mean duration of mechanical ventilation (MV) was (51.49+/-66.01) hours. (2)The concentrations of INS, ISI, C-P, Cor, Gluc, TNF-alpha, sTNFRI and sTNFRII in 47 SHG patients with critical illness were significantly higher than those in normal controls, except for SS, the differences among groups were significant (P<0.05 or P<0.01). (3)The results of analysis of severity of SHG showed that the more severe SHG was, the higher C-P and INS were, and the less prominent ISI was. (4)Analysis of scores of APACHEII in 47 cases of SHG showed that BG was not increased, but duration of MV, Cor, Gluc, SS, TNF-alpha, sTNFRI and sTNFRII were significantly increased with higher scores of APACHEII. (5)The effect of SHG was significant on MV (F=10.438,P<0.01), but not significant for outcome and days of stay in ICU. (6)The main correlative factors of BG were respectively concentrations of INS (r=0.674, P<0.01), C-P(r=0.552,P<0.01), ISI (r=-0.787, P<0.01), APACHE II(r=0.267,P<0.05) and sTNFRI(r=0.465, P<0.01) 
520 |a CONCLUSION: These results show that main reason of SHG in critical illness is IR. There is no strong significant correlation between acute stress hormones and the level of SHG. sTNFRI has an influence on SHG. However, the over release of TNF-alpha and sTNFRII could be the results of seriousness of the critical illness. There is closely correlation between BG and MV, but not with the age, outcome and days of stay in ICU. The strategy of control and therapy of SHG should be alleviation of stress and improve the utilization of BG in the tissue, and increase sensitivity of INS in the tissue 
650 4 |a English Abstract 
650 4 |a Journal Article 
650 7 |a C-Peptide  |2 NLM 
650 7 |a Insulin  |2 NLM 
650 7 |a Tumor Necrosis Factor-alpha  |2 NLM 
650 7 |a Glucagon  |2 NLM 
650 7 |a 9007-92-5  |2 NLM 
650 7 |a Hydrocortisone  |2 NLM 
650 7 |a WI4X0X7BPJ  |2 NLM 
700 1 |a Wang, Xiao-hong  |e verfasserin  |4 aut 
700 1 |a Ma, Shao-lin  |e verfasserin  |4 aut 
700 1 |a Yang, Xiao-jun  |e verfasserin  |4 aut 
700 1 |a Wang, Xiao-qi  |e verfasserin  |4 aut 
700 1 |a Ding, Huan  |e verfasserin  |4 aut 
700 1 |a Liu, Ming  |e verfasserin  |4 aut 
700 1 |a He, Lan-jie  |e verfasserin  |4 aut 
700 1 |a Ma, Xiao-wei  |e verfasserin  |4 aut 
700 1 |a Ma, Xi-gang  |e verfasserin  |4 aut 
773 0 8 |i Enthalten in  |t Zhongguo wei zhong bing ji jiu yi xue = Chinese critical care medicine = Zhongguo weizhongbing jijiuyixue  |d 1998  |g 18(2006), 12 vom: 14. Dez., Seite 751-4  |w (DE-627)NLM098227793  |x 1003-0603  |7 nnns 
773 1 8 |g volume:18  |g year:2006  |g number:12  |g day:14  |g month:12  |g pages:751-4 
912 |a GBV_USEFLAG_A 
912 |a SYSFLAG_A 
912 |a GBV_NLM 
912 |a GBV_ILN_350 
951 |a AR 
952 |d 18  |j 2006  |e 12  |b 14  |c 12  |h 751-4